Among 11 analysts covering uniQure N.V. (NASDAQ:QURE), 8 have Buy rating, 0 Sell and 3 Hold. Therefore 73% are positive. uniQure N.V. had 21 analyst reports since August 7, 2015 according to SRatingsIntel. Jefferies downgraded the shares of QURE in report on Tuesday, November 22 to “Hold” rating. The company was maintained on Monday, September 21 by Piper Jaffray. The firm has “Outperform” rating by Leerink Swann given on Tuesday, September 22. The stock of Uniqure NV (NASDAQ:QURE) has “Buy” rating given on Thursday, August 27 by Chardan Capital Markets. The firm has “Buy” rating by Roth Capital given on Monday, September 21. As per Wednesday, February 24, the company rating was reinitiated by H.C. Wainwright. As per Thursday, October 1, the company rating was maintained by Chardan Capital Markets. The rating was maintained by Oppenheimer with “Outperform” on Monday, September 21. The stock of Uniqure NV (NASDAQ:QURE) earned “Buy” rating by TH Capital on Monday, November 30. WallachBeth Capital maintained it with “Buy” rating and $33 target in Friday, August 28 report. See Uniqure NV (NASDAQ:QURE) latest ratings:
22/11/2016 Broker: Jefferies Old Rating: Buy New Rating: Hold Old Target: $28.00 New Target: $8.00 Downgrade
16/11/2016 Broker: PiperJaffray Old Rating: Overweight New Rating: Neutral Downgrade
16/11/2016 Broker: Piper Jaffray Old Rating: Overweight New Rating: Neutral Downgrade
Analysts expect CVR Partners LP (NYSE:UAN) to report $-0.02 EPS on April, 27 before the open.They anticipate $0.27 EPS change or 108.00% from last quarter’s $0.25 EPS. After having $-0.13 EPS previously, CVR Partners LP’s analysts see -84.62% EPS growth. About 15,309 shares traded. CVR Partners LP (NYSE:UAN) has declined 12.32% since September 19, 2016 and is downtrending. It has underperformed by 23.98% the S&P500.
Among 2 analysts covering CVR Partners (NYSE:UAN), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. CVR Partners had 4 analyst reports since August 5, 2015 according to SRatingsIntel. Zacks upgraded CVR Partners LP (NYSE:UAN) rating on Wednesday, August 5. Zacks has “Hold” rating and $14 target. The firm has “Buy” rating by Goldman Sachs given on Monday, March 20.
CVR Partners, LP is a limited partnership formed by CVR Energy, Inc. to own, operate and grow its nitrogen fertilizer business. The company has market cap of $556.91 million. The Firm produces and distributes nitrogen fertilizer products, which are used by farmers to manage the yield and quality of their crops. It currently has negative earnings. As of December 31, 2016, the Company produced its nitrogen fertilizer products at two manufacturing facilities, located in Coffeyville, Kansas and East Dubuque, Illinois.
Investors sentiment increased to 0.86 in 2016 Q4. Its up 0.21, from 0.65 in 2016Q3. It is positive, as 13 investors sold CVR Partners LP shares while 22 reduced holdings. 17 funds opened positions while 13 raised stakes. 23.29 million shares or 6.03% more from 21.96 million shares in 2016Q3 were reported. Raging Management Lc reported 769,140 shares. The New Jersey-based Private Advisor Group Incorporated Ltd Liability Corporation has invested 0% in CVR Partners LP (NYSE:UAN). Vantage Advsr Ltd Liability Corporation reported 0% of its portfolio in CVR Partners LP (NYSE:UAN). California Employees Retirement reported 177,500 shares. Blackrock has invested 0% in CVR Partners LP (NYSE:UAN). Susquehanna Intll Group Ltd Liability Partnership holds 0% in CVR Partners LP (NYSE:UAN) or 27,180 shares. Greenwich Mngmt Inc holds 94,829 shares. Da Davidson Co holds 0% in CVR Partners LP (NYSE:UAN) or 4,200 shares. Ameriprise Fincl has 0% invested in CVR Partners LP (NYSE:UAN). Comml Bank Of America De holds 0% or 27,633 shares in its portfolio. Kcg Hldg has 0.01% invested in CVR Partners LP (NYSE:UAN) for 45,333 shares. Pekin Singer Strauss Asset Management Il reported 95,428 shares or 0.05% of all its holdings. Janney Montgomery Scott Limited Liability Company has invested 0% in CVR Partners LP (NYSE:UAN). Wells Fargo Mn reported 0% in CVR Partners LP (NYSE:UAN). Indexiq Advsrs Limited Liability Corporation holds 17,944 shares or 0.01% of its portfolio.
Since November 4, 2016, it had 1 insider buy, and 22 insider sales for $81.13 million activity. Another trade for 989,000 shares valued at $6.03 million was sold by Blackstone Holdings I L.P.. The insider GSO CAPITAL PARTNERS LP sold $6.03 million. PYTOSH MARK A also bought $83,910 worth of CVR Partners LP (NYSE:UAN) shares.
About 10,567 shares traded. Uniqure NV (NASDAQ:QURE) has declined 35.01% since September 19, 2016 and is downtrending. It has underperformed by 46.67% the S&P500.
uniQure N.V. is a gene therapy company. The company has market cap of $132.41 million. The Firm is engaged in developing single treatments with curative results for patients suffering from genetic and other severe diseases. It currently has negative earnings. The Firm is advancing a focused pipeline of gene therapies that have been developed both internally and through partnerships.
